My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 464

    1.

    The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases.

    Han C, Smolen JS, Kavanaugh A, van der Heijde D, Braun J, Westhovens R, Zhao N, Rahman MU, Baker D, Bala M.

    Arthritis Res Ther. 2007;9(5):R103.

    PMID:
    17922913
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    2.

    Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.

    Maini RN, Breedveld FC, Kalden JR, Smolen JS, Furst D, Weisman MH, St Clair EW, Keenan GF, van der Heijde D, Marsters PA, Lipsky PE; Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

    Arthritis Rheum. 2004 Apr;50(4):1051-65.

    PMID:
    15077287
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    3.

    Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).

    Antoni CE, Kavanaugh A, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman D, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, Kalden JR, Smolen J.

    Arthritis Rheum. 2005 Apr;52(4):1227-36. Erratum in: Arthritis Rheum. 2005 Sep;52(9):2951.

    PMID:
    15818699
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    4.

    The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study.

    Heiberg MS, Koldingsnes W, Mikkelsen K, Rødevand E, Kaufmann C, Mowinckel P, Kvien TK.

    Arthritis Rheum. 2008 Feb 15;59(2):234-40.

    PMID:
    18240258
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    5.

    Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis.

    Feldman SR, Gottlieb AB, Bala M, Wu Y, Eisenberg D, Guzzo C, Li S, Dooley LT, Menter A.

    Br J Dermatol. 2008 Sep;159(3):704-10. Epub 2008 Jul 9.

    PMID:
    18627375
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study.

    Revicki DA, Menter A, Feldman S, Kimel M, Harnam N, Willian MK.

    Health Qual Life Outcomes. 2008 Oct 2;6:75.

    PMID:
    18831744
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    7.

    Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis.

    Kavanaugh A, Antoni C, Krueger GG, Yan S, Bala M, Dooley LT, Beutler A, Guzzo C, Gladman D.

    Ann Rheum Dis. 2006 Apr;65(4):471-7. Epub 2005 Aug 11.

    PMID:
    16096330
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    8.

    Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.

    Reich K, Nestle FO, Papp K, Ortonne JP, Wu Y, Bala M, Evans R, Guzzo C, Li S, Dooley LT, Griffiths CE.

    Br J Dermatol. 2006 Jun;154(6):1161-8.

    PMID:
    16704649
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    [Measurement of quality of life in patients with active ankylosing spondylitis being treated with infliximab-a comparison of SF-36 and SF-12].

    Haibel H, Niewerth M, Brandt J, Rudwaleit M, Listing J, Sieper J, Braun J.

    Z Rheumatol. 2004 Oct;63(5):393-401. German.

    PMID:
    15517300
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study.

    Heiberg MS, Nordvåg BY, Mikkelsen K, Rødevand E, Kaufmann C, Mowinckel P, Kvien TK.

    Arthritis Rheum. 2005 Aug;52(8):2506-12.

    PMID:
    16052584
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    11.

    Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.

    Doyle MK, Rahman MU, Han C, Han J, Giles J, Bingham CO 3rd, Bathon J.

    Semin Arthritis Rheum. 2009 Oct;39(2):123-31. Epub 2008 Sep 27. Review.

    PMID:
    18823645
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139].

    Ortonne JP, Shear N, Shumack S, Henninger E; CLEAR Multinational Study Group.

    BMC Dermatol. 2005 Dec 16;5:13.

    PMID:
    16359548
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    13.

    Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).

    van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P, Braun J; Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group.

    Arthritis Rheum. 2005 Feb;52(2):582-91.

    PMID:
    15692973
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    14.

    Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study.

    Davis JC Jr, Revicki D, van der Heijde DM, Rentz AM, Wong RL, Kupper H, Luo MP.

    Arthritis Rheum. 2007 Aug 15;57(6):1050-7.

    PMID:
    17665483
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    15.

    Health-related quality-of-life effects of oxaprozin and nabumetone in patients with osteoarthritis of the knee.

    Zhao SZ, Dedhiya SD, Bocanegra TS, Fort JG, Kuss ME, Rush SM.

    Clin Ther. 1999 Jan;21(1):205-17.

    PMID:
    10090436
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate.

    Schiff M, Keiserman M, Codding C, Songcharoen S, Berman A, Nayiager S, Saldate C, Li T, Aranda R, Becker JC, Lin C, Cornet PL, Dougados M.

    Ann Rheum Dis. 2008 Aug;67(8):1096-103. Epub 2007 Nov 29.

    PMID:
    18055472
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    17.

    Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.

    Feldman SR, Gordon KB, Bala M, Evans R, Li S, Dooley LT, Guzzo C, Patel K, Menter A, Gottlieb AB.

    Br J Dermatol. 2005 May;152(5):954-60.

    PMID:
    15888152
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    A review of infliximab use in ulcerative colitis.

    Wilhelm SM, McKenney KA, Rivait KN, Kale-Pradhan PB.

    Clin Ther. 2008 Feb;30(2):223-30. Review.

    PMID:
    18343261
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.

    van der Heijde D, Landewé R, Baraliakos X, Houben H, van Tubergen A, Williamson P, Xu W, Baker D, Goldstein N, Braun J; Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group.

    Arthritis Rheum. 2008 Oct;58(10):3063-70.

    PMID:
    18821688
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    20.

    Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.

    Mease PJ, Revicki DA, Szechinski J, Greenwald M, Kivitz A, Barile-Fabris L, Kalsi J, Eames J, Leirisalo-Repo M.

    J Rheumatol. 2008 Jan;35(1):20-30. Epub 2007 Nov 15.

    PMID:
    18050385
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filter your results:

      Find related data

      Recent activity

      You are here: NCBI > Literature > PubMed
      Write to the Help Desk